Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −55,033−100.0% | Sold out | Holders |
| Q1 2025 | 55,033 | $87.5K | <0.1% | −2,554−4.4% | Reduced | Holders |
| Q4 2024 | 57,587 | $174.5K | <0.1% | +1,371+2.4% | Added | Holders |
| Q3 2024 | 56,216 | $206.9K | <0.1% | +802+1.4% | Added | Holders |
| Q2 2024 | 55,414 | $226.6K | <0.1% | +5,360+10.7% | Added | Holders |
| Q1 2024 | 50,054 | $788.9K | <0.1% | +2,147+4.5% | Added | Holders |
| Q4 2023 | 47,907 | $725.8K | <0.1% | −4,218−8.1% | Reduced | Holders |
| Q3 2023 | 52,125 | $1.05M | <0.1% | +8,407+19.2% | Added | Holders |
| Q2 2023 | 43,718 | $1.23M | <0.1% | +43,718 | New | Holders |